PA
SENS icon

PharVision Advisers’s Senseonics Holdings Inc SENS Stock Holding History

PharVision Advisers’s Portfolio SENS Stock Details SENS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25,787
Closed -$142K – 553
2025
Q4 		$142K Buy
+25,787
New +$179K 0.07% 620

Other funds holding SENS

SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

PharVision Advisers's SENS Position: Q1 2026 in Review

PharVision Advisers sold out of Senseonics Holdings Inc (SENS) in Q1 2026, closing a stake of 25,787 shares — an estimated $142K sold.

PharVision Advisers first reported a position in SENS in Q4 2025 and held it in 1 quarter. The position peaked at $142K in Q4 2025. 88 funds tracked by Wall St. Rank hold SENS as of Q1 2026.

  • PharVision Advisers reported no remaining Senseonics Holdings Inc position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 25,787 Senseonics Holdings Inc shares in Q1 2026, an estimated $142K.
  • PharVision Advisers first reported a position in Senseonics Holdings Inc in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's Senseonics Holdings Inc position peaked at $142K in Q4 2025.
  • 88 funds tracked by Wall St. Rank held Senseonics Holdings Inc as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.